ITGB1 and metabolic dysfunction-associated steatohepatitis: In 2019, Guo et al. reported that EVs enriched with Integrin Beta-1 (ITGβ1), which are released from LPC-treated hepatocytes, mediate monocyte adhesion and promote liver inflammation in a murine model of NASH.